Page last updated: 2024-09-02

fingolimod hydrochloride and threonine

fingolimod hydrochloride has been researched along with threonine in 2 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(threonine)
Trials
(threonine)
Recent Studies (post-2010) (threonine)
2,7711572,06210,383982,176

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Camp, SM; Chiang, ET; Dudek, SM; Garcia, JG; Natarajan, V; Singleton, PA; Usatyuk, PV; Zhao, Y1
Berman, JN; Feng, H; Ganem, NJ; Hwang, SK; Laroche, FJF; Li, S; Liu, CT; Nguyen, G; Quinton, RJ; Shen, N; Singh, A; Thiagalingam, S; Wong, CK; Yu, W1

Other Studies

2 other study(ies) available for fingolimod hydrochloride and threonine

ArticleYear
Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.
    Cellular signalling, 2007, Volume: 19, Issue:8

    Topics: Adenoviridae; Capillary Permeability; Cells, Cultured; Cytoskeleton; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lung; Models, Biological; Phosphorylation; Propylene Glycols; Pulmonary Artery; rac1 GTP-Binding Protein; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine; Threonine

2007
S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720.
    Cells, 2023, 03-23, Volume: 12, Issue:7

    Topics: Animals; Fingolimod Hydrochloride; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Threonine; Triple Negative Breast Neoplasms; Zebrafish

2023